文献速递呼吸危重症与机械通气

超肺保护性有创机械通气策略的风险与获益:聚焦体外支持

Risks and Benefits of Ultra-Lung-Protective Invasive Mechanical Ventilation Strategies with a Focus on Extracorporeal Support.
PubMed 文献 · Am J Respir Crit Care Med · 2022-01-01

本文为危重症视角综述,讨论超肺保护性通气(低于现行标准的气道压和潮气量)在ARDS中的应用争议。驱动压和呼吸系统弹性等生理参数可能预测获益人群,但呼吸性酸中毒限制其应用,体外CO2清除(ECCO2R)或ECMO可辅助实现,却伴随血液学并发症,且近期大型RCT未显示ECCO2R辅助超肺保护通气的获益。仅极重度ARDS患者使用ECMO实现的超肺保护通气可能风险获益比有利。

要点

  • 超肺保护通气需更低气道压和潮气量,呼吸性酸中毒是主要限制因素。
  • 驱动压和呼吸系统弹性可能预测超肺保护通气的获益人群。
  • ECCO2R辅助超肺保护通气近期大型RCT未显示获益,且存在血液学并发症风险。

核心结论

  • 超肺保护性通气在多数ARDS患者中获益未证实,仅极重度ARDS经ECMO实现时可能风险获益比有利。

研究设计与样本

  • 危重症视角综述,讨论超肺保护性有创机械通气策略的风险与获益及体外支持的作用。

主要发现

  • 驱动压和呼吸系统弹性等生理参数可能预测超肺保护通气的获益人群。
  • 呼吸性酸中毒常限制超肺保护通气的应用,需ECMO或ECCO2R清除CO2辅助。
  • 体外支持策略伴血液学并发症,低血流量下使用高血流量设计装置时尤甚。
  • 近期大型RCT未显示ECCO2R辅助的超肺保护通气策略获益。
  • 仅极重度ARDS患者使用ECMO实现的超肺保护通气被提示风险获益比有利。

临床怎么用

  • 选择超肺保护通气前应评估驱动压和呼吸系统弹性等生理参数以识别可能获益者。
  • 应用体外CO2清除辅助超肺保护通气时需警惕血液学并发症,尤其低血流量运行高血流量设计装置时。
  • 极重度ARDS可考虑ECMO辅助实现超肺保护通气,其余患者不宜常规推广。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lung-protective ventilation strategies are the current standard of care for patients with acute respiratory distress syndrome in an effort to provide adequate ventilatory requirements while minimizing ventilator-induced lung injury. Some patients may benefit from ultra-lung-protective ventilation, a strategy that achieves lower airway pressures and Vt than the current standard. Specific physiological parameters beyond severity of hypoxemia, such as driving pressure and respiratory system elastance, may be predictive of those most likely to benefit. Because application of ultra-lung-protective ventilation is often limited by respiratory acidosis, extracorporeal membrane oxygenation or extracorporeal carbon dioxide removal, which remove carbon dioxide from blood, is an attractive option. These strategies are associated with hematological complications, especially when applied at low blood-flow rates with devices designed for higher blood flows, and a recent large randomized controlled trial failed to show a benefit from an extracorporeal carbon dioxide removal-facilitated ultra-lung-protective ventilation strategy. Only in patients with very severe forms of acute respiratory distress syndrome has the use of an ultra-lung-protective ventilation strategy-accomplished with extracorporeal membrane oxygenation-been suggested to have a favorable risk-to-benefit profile. In this critical care perspective, we address key areas of controversy related to ultra-lung-protective ventilation, including the trade-offs between minimizing ventilator-induced lung injury and the risks from strategies to achieve this added protection. In addition, we suggest which patients might benefit most from an ultra-lung-protective strategy and propose areas of future research.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Abrams D, Agerstrand C, Beitler JR, et al. Risks and Benefits of Ultra-Lung-Protective Invasive Mechanical Ventilation Strategies with a Focus on Extracorporeal Support. Am J Respir Crit Care Med. 2022. PMID: 35044901. doi:10.1164/rccm.202110-2252CP

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。